Catalyst Wire Dossier Catalyst Wire Dossier

BIIF 1149 BS

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BIIF 1149 BS, covering 2014-07-25 to 2014-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacodynamics After Oral Administration of BIIF 1149 BS in Healthy Male Volunteers [Phase 1]

See pricing